That's just one of the burning questions we were fortunate enough to ask ETF Analyst James Seyffart, CFA, CAIA, one half of the Bloomberg Intelligence ETF team.
With advisor and platform due diligence still taking place, and major asset allocators still moving the funds through multiple permission tiers – even after some approved their distribution – it could still be months before a clear picture emerges, says James.
Meanwhile, BlackRock's iShares Bitcoin Trust (IBIT) and other 'CFB Six' ETFs using our CME CF BRRNY index for NAV calculation, continue to break records, with IBIT AuM recently hitting $10 billion, the fastest ETF to achieve this milestone.
Listen in for more exclusive insights from one of the best-known experts in the space:
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Notice of the Demising of CF IoTeX-Dollar Spot Rate

CF Benchmarks
Hyperliquid returns ~83 cents of every fee dollar to HYPE holders via buybacks, far more than Coinbase or Robinhood turn into profit. On fully diluted supply it trades near 61x earnings; our modeling assumes growing market share and puts fair value near $106, about 89% above the June 10 price.

Mark Pilipczuk
Announcement of Consultation on Changes to the CME CF Real Time Indices Methodology

CF Benchmarks
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.